Tech Company Financing Transactions
BlueWind Medical Funding Round
On 5/9/2022, BlueWind Medical raised $64 million in Series B investment from ConvaTec and private investors.
Transaction Overview
Company Name
Announced On
5/9/2022
Transaction Type
Venture Equity
Amount
$64,000,000
Round
Series B
Investors
ConvaTec (Lead Investor)
Proceeds Purpose
The company intends to use the funds to grow its commercial presence in anticipation of potential FDA marketing clearance for its RENOVA iStim implantable neuromodulation device.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Post Office Box 4101 6 Maskit Street Building B
Herzliya, 4614002
Israel
Herzliya, 4614002
Israel
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
A Medical device company developing novel wireless Neuro-stimulation device for the treatment of various clinical indications. BlueWind developed a unique platform technology for a leadless, battery-less miniature implant which can be positioned in the vicinity of numerous peripheral nerves.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Lemaitre
Browse more venture capital transactions:
Prev: 5/9/2022: PocketLaw venture capital transaction
Next: 5/9/2022: BioGenCell venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs